Previously reported enhanced sensitivity of AML cell lines to venetoclax after silencing of CLEVER-1 suggests that CLEVER-1 inhibition may increase the sensitivity of malignant blasts to cytotoxic agents13. The gene discussed is STAB1; the disease is acute myeloid leukemia.